Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Urologic ClinicsReferences
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors. Available at: https://clinicaltrials.gov/ct2/show/NCT03067181.
- Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009.World J Urol. 2015; 33: 623-631
- Increasing incidence of testicular germ cell tumors among racial/ethnic minorities in the United States.Cancer Epidemiol Biomarkers Prev. 2020; 29: 1237-1245
- Diagnosis and treatment of early stage testicular cancer: AUA guideline.J Urol. 2019; 202: 272-281
- ESMO consensus conference on testicular germ cell cancer: Diagnosis, treatment and follow-up.Ann Oncol. 2018; 29: 1658-1686
- International germ cell consensus classification: a prognostic factor- based staging system for metastatic germ cell cancers.J Clin Oncol. 1997; 15: 594-603
- Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): Results from the IGCCCG update consortium.J Clin Oncol. 2021; 39: 1563-1574
- Survival and new prognosticators in metastatic seminoma: Results from the IGCCCG-update consortium.J Clin Oncol. 2021; 39: 1553-1562
- Liquid biopsies in the clinical management of germ cell tumor patients: State-of-the-art and future directions.Int J Mol Sci. 2021; 22: 1-22
- Campbell-walsh urology.10th ed. Elsevier Saunders, Philadelphia, PA2016
- The role of biologic tumor markers in testicular cancer.Cancer. 1980; 45: 1755-1761
- Biological markers in urologic cancer.Cancer. 1987; 60: 464-472
- Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance.Open Access J Urol. 2011; 4: 1-8
- Alpha-1 antitrypsin (AAT) and alphafoetoprotein (AFP) in sera of patients with germ-cell neoplasms: Value as tumour markers in patients with endodermal sinus tumour (yolk sac tumour).Int J Cancer. 1977; 19: 741-746
- Circulating Serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as Biomarkers in Patients with Testicular Germ Cell Cancer.J Urol. 2015; 193: 331-337
- Mildly elevated serum alpha-fetoprotein (AFP) among patients with testicular cancer may not be associated with residual cancer or need for treatment.Ann Oncol. 2017; 28: 899-902
- Serum Levels of MicroRNA miR-371a-3p: a sensitive and specific new biomarker for germ cell tumours.Eur Urol. 2017; 71: 213-220
- Human chorionic gonadotropin in cancer.Clin Biochem. 2004; 37: 549-561
- False elevations of human chorionic gonadotropin associated to latrogenic hypogonadism in gonadal germ cell tumors.Cancer. 1987; 60: 2489-2493
- Falsely positive specific human chorionic gonadotropin assays in patients with testicular tumors: Conversion to negative with testosterone administration.J Urol. 1979; 122: 126-128
- Spurious rise in human chorionic gonadotropin induced by marihuana in patients with testicular cancer.N Engl J Med. 1980; 303: 1177
- Endocrine effects of marijuana in the male: preclinical studies.NIDA Res Monogr. 1984; 44: 46-64
- Marijuana use does not spuriously elevate serum human chorionic gonadotropin levels.Urology. 1985; 25: 605-606
- Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor.J Urol. 1988; 140: 986-989
- Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors.Cancer Res. 1990; 50: 5904-5910
- Heterophile Antibody Interference led to Unneeded Chemotherapy in a Testicular Cancer Patient.Urol Case Reports. 2016; 9: 1-3
- Heterophilic antibody interference in immunometric assays.Best Pract Res Clin Endocrinol Metab. 2013; 27: 647-661
- Identification of microRNAs From the miR-371∼373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors.Am J Clin Pathol. 2011; 135: 119-125
- Developing a highly specific biomarker for germ cell malignancies: Plasma MiR371 expression across the germ cell malignancy spectrum.J Clin Oncol. 2019; 37: 3090-3098
- A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.Adv Exp Med Biol. 2007; 604: 17-46
- Serum MicroRNA-371a-3p levels predict viable germ cell tumor in chemotherapy-naïve patients undergoing retroperitoneal lymph node dissection.Eur Urol. 2020; 77: 290-292
- Serum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumor.J Urol. 2018; 200: 126-135
- Clinical utility of plasma miR-371a-3p in germ cell tumors.J Cell Mol Med. 2019; 23: 1128-1136
- Functional results of orthotopic ileal neobladder with serous-lined extramural ureteral reimplantation: experience with 450 patients.J Urol. 2001; 165: 1427-1432
- Accurate primary germ cell cancer diagnosis using serum based microRNA detection (ampTSmiR test).Oncotarget. 2017; 8: 58037-58049
- MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.Br J Cancer. 2012; 107: 1754-1760
- Serum Levels of MicroRNA-371a-3p (M371 Test) as a new biomarker of testicular germ cell tumors: Results of a prospective multicentric study.J Clin Oncol. 2019; 37: 1412-1423
- Integrated molecular characterization of testicular germ cell tumors.Cell Rep. 2018; 23: 3392-3406
- Combining hypermethylated rassf1a detection using ddpcr with mir-371a-3p testing: an improved panel of liquid biopsy biomarkers for testicular germ cell tumor patients.Cancers (Basel). 2021; 13: 1-15
- Emerging prognostic biomarkers in testicular germ cell tumors: Looking beyond established practice.Front Oncol. 2018; 8: 1-7
- Integrated expression of circulating miR375 and miR371 to identify teratoma and active germ cell malignancy components in malignant germ cell tumors.Eur Urol. 2021; 79: 16-19
- Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin.J Cancer Res Clin Oncol. 2021; 147: 435-443
- Role of the Ras-association domain family 1 tumor suppressor gene in human cancers.Cancer Res. 2005; 65: 3497-3508
A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for Standard Risk Pediatric and Adult Patients With Germ Cell Tumors. Available at: https://clinicaltrials.gov/ct2/show/NCT03067181.
- NCT04435756. A Study of miRNA 371 in Patients With Germ Cell Tumors.(Available at:)
- Cell-Free Circulating DNA: diagnostic value in patients with testicular germ cell cancer.J Urol. 2009; 181: 363-371
- Circulating mitochondria DNA, a non-invasive cancer diagnostic biomarker candidate.Mitochondrion. 2019; 47: 238-243
- Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker.BJU Int. 2009; 104: 48-52
- Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model.Cancer Cell Int. 2019; 19: 1-13
- Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques.Bone Marrow Transpl. 1998; 22: 771-775
- Detection of circulating testicular cancer cells in peripheral blood.Cancer Lett. 1999; 143: 57-62
- Detection of germ-cell tumor cells in the peripheral blood by nested reverse transcription-polymerase chain reaction for alpha-fetoprotein-messenger RNA and beta human chorionic gonadotropin-messenger RNA.Cancer Res. 2000; 60: 3170-3174
- Detection of circulating tumor cells (CTCs) in patients with testicular germ cell tumors.Methods Mol Biol. 2021; 2195: 245-261
Article info
Footnotes
Funding: None.